BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
EngMab is defunct.

Fate: Bought by Celgene, Sep 2016, $625M + $2.4B milestones


------------------
If you believe any of this information is incorrect, please let us know.